08:07 AM EST, 02/25/2025 (MT Newswires) -- Kiniksa Pharmaceuticals International ( KNSA ) reported a Q4 loss Tuesday of $0.12 per diluted share, swinging from earnings of $0.35 per share a year earlier.

Analysts polled by FactSet expected earnings of $0.02.

Revenue for the quarter ended Dec. 31 was $122.5 million, up from $83.4 million a year earlier.

Analysts surveyed by FactSet expected $123.4 million.

Shares of the biotech firm were down more than 6% in recent premarket activity.

Price: 18.28, Change: -1.35, Percent Change: -6.89